Lila J Finney Rutten
Overview
Explore the profile of Lila J Finney Rutten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
4035
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Basappa S, Finney Rutten L, Hruska C, Olson J, Jacobson D, Rhodes D
Mayo Clin Proc
. 2023 Feb;
98(2):278-289.
PMID: 36737116
Objective: To evaluate how breast cancers come to clinical attention (mode of detection [MOD]) in a population-based cohort, determine the relative frequency of different MODs, and characterize patient and tumor...
22.
Felzer J, Finney Rutten L, Wi C, LeMahieu A, Beam E, Juhn Y, et al.
Transpl Infect Dis
. 2023 Jan;
25(2):e14010.
PMID: 36715676
Introduction: Vaccinations against preventable respiratory infections such as Streptococcus pneumoniae and influenza are important in immunosuppressed solid organ transplant (SOT) recipients. Little is known about the role of age, race,...
23.
Herrin J, Finney Rutten L, Ruddy K, Kroenke K, Cheville A
Trials
. 2023 Jan;
24(1):21.
PMID: 36624460
We previously described the hypotheses, outcomes, design, and analysis for E2C2, a pragmatic stepped-wedge trial to assess an intervention to improve symptom control in patients with cancer. Subsequent consideration of...
24.
Miller-Wilson L, Finney Rutten L, Van Thomme J, Ozbay A, Laffin J, Limburg P
Prev Med Rep
. 2022 Dec;
30:102032.
PMID: 36531112
Colorectal cancer (CRC) is the third leading cause of cancer death in the US. Early detection improves CRC outcomes and multiple options are endorsed for CRC screening; however, adherence remains...
25.
Zhu X, Weiser E, Griffin J, Limburg P, Finney Rutten L
Prev Med Rep
. 2022 Dec;
30:102047.
PMID: 36531086
Colorectal cancer (CRC) screening rates remain suboptimal in the US. We examined patient-focused concerns and influence of various factors (e.g., test attributes, provider recommendation) on CRC screening decision-making. We conducted...
26.
Vachon C, Norman A, Prasad K, Jensen D, Schaeferle G, Vierling K, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2022 Oct;
6(6):605-617.
PMID: 36277251
Objective: To estimate rates and identify factors associated with asymptomatic COVID-19 in the population of Olmsted County during the prevaccination era. Patients And Methods: We screened first responders (n=191) and...
27.
Flanagan C, Finney Rutten L, Kisiel J, Lent J, Bachtold J, Swartz A, et al.
Contemp Clin Trials Commun
. 2022 Oct;
30:101016.
PMID: 36276262
Objectives: Alaska Native (AN) people experience twice the rate of colorectal cancer (CRC) as US Whites. There is a need for increased screening and early detection. We describe the development...
28.
Griffin J, Finney Rutten L, Zhu X, Feng Z, Rogers C, Marsh T, et al.
Contemp Clin Trials
. 2022 Jul;
119:106852.
PMID: 35842109
Background: Colorectal cancer (CRC) screening is underutilized despite evidence that screening improves survival. Since healthcare provider recommendation is a strong predictor of CRC screening completion, providers are encouraged to engage...
29.
Greenberg A, Falisi A, Finney Rutten L, Chou W, Patel V, Moser R, et al.
J Med Internet Res
. 2022 Jun;
24(6):e39719.
PMID: 35724378
[This corrects the article DOI: .].
30.
Chamberlain A, St Sauver J, Boyd C, Finney Rutten L, Fan C, Jacobson D, et al.
J Multimorb Comorb
. 2022 Jun;
12:26335565221105448.
PMID: 35665073
Background: Persons who accumulate chronic conditions at a rate faster than their peers may experience accelerated aging and poor health outcomes, including functional limitations. Methods: Adults aged ≥40 years who...